Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma: Results of a multicenter phase II trial
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Reid Merryman, Danielle Wallace, Robert Redd, Heather Walker, Rafaella Tringale, Vanessa Kats, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Audrey Sigmund, Inhye Ahn, Amy Bessnow, Jennifer R. Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Sumana Devata, Carla Casulo, Kami Maddocks, Mark Murakami, Philippe Armand, Yazeed Sawalha
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417016156
Cites:
Cited by:
Related to: